Research challenges in chronic diseases: Difficult to treat depression
Main Authors: | A. John Rush, Harold A. Sackeim, Charles R. Conway, Mark T. Bunker, Steven D. Hollon, Koen Demyttenaere, Allan H. Young, Scott T. Aaronson, Maxine Dibue, Michael E. Thase |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Brain Stimulation |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1935861X2100694X |
Similar Items
-
A Prospective, Multi-center Randomized, Controlled, Blinded Trial of Vagus Verve Stimulation for Difficult to Treat Depression: the RECOVER Trial
by: Charles Conway, et al.
Published: (2023-03-01) -
A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment
by: Charles Conway, et al.
Published: (2021-11-01) -
The mechanisms of action of vagus nerve stimulation in difficult-to-treat depression: An update
by: Harold Sackeim
Published: (2021-11-01) -
Vagus nerve stimulation: Changing the paradigm for chronic difficult to treat depression
by: Scott Aaronson
Published: (2021-11-01) -
A large, prospective, double-blind trial of vagus nerve stimulation in difficult to treat depression
by: CHARLES CONWAY
Published: (2021-11-01)